No Record Found
Sector
PharmaceuticalsOpen
₹692Prev. Close
₹696Turnover(Lac.)
₹85.61Day's High
₹701.5Day's Low
₹685.152 Week's High
₹842.952 Week's Low
₹544.1Book Value
₹120.68Face Value
₹1Mkt Cap (₹ Cr.)
1,992.38P/E
35.51EPS
19.61Divi. Yield
0.66No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 2.89 | 2.89 | 2.92 | 2.92 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 323.72 | 285.6 | 287.85 | 262.2 |
Net Worth | 326.61 | 288.49 | 290.77 | 265.12 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 332.84 | 261.47 | 223.17 | 206.88 |
yoy growth (%) | 27.29 | 17.16 | 7.87 | 12.2 |
Raw materials | -140.18 | -117.07 | -95.63 | -83.37 |
As % of sales | 42.11 | 44.77 | 42.84 | 40.29 |
Employee costs | -41.7 | -39.36 | -33.85 | -29.67 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 81.9 | 34.45 | 31.08 | 35.09 |
Depreciation | -3.66 | -4.35 | -2.9 | -2.04 |
Tax paid | -20.71 | -9.37 | -12.9 | -11.98 |
Working capital | 78.27 | -1.63 | 12.83 | 6.67 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 27.29 | 17.16 | 7.87 | 12.2 |
Op profit growth | 143.39 | 8.16 | -5.46 | -4.82 |
EBIT growth | 137.64 | 11.08 | -11.4 | 1.35 |
Net profit growth | 143.94 | 25.58 | -8.37 | -2.76 |
| Particulars (Rupees in Crores.) | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 | Mar-2013 |
|---|---|---|---|---|---|
Gross Sales | 231.7 | 194.52 | 174.1 | 147.46 | 144.07 |
Excise Duty | 10.61 | 9.05 | 8.32 | 7.05 | 7.4 |
Net Sales | 221.1 | 185.47 | 165.78 | 140.41 | 136.66 |
Other Operating Income | 2.88 | 1.28 | 0.79 | 1.32 | 0.99 |
Other Income | 7.52 | 5.68 | 4.53 | 2.94 | 4.26 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,779.7 | 91.37 | 4,27,033.64 | 564.22 | 0.9 | 4,511.27 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,373 | 67.31 | 1,69,211 | 696 | 0.47 | 2,660 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,686.5 | 58.51 | 1,24,868.91 | 597 | 0.16 | 2,707 | 249.83 |
Cipla Ltd CIPLA | 1,511.8 | 23.49 | 1,22,082.5 | 1,210.53 | 1.06 | 4,495.16 | 411.56 |
Dr Reddys Laboratories Ltd DRREDDY | 1,243.9 | 19.24 | 1,03,872.78 | 387.3 | 0.64 | 4,602.9 | 377.56 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman / Executive Director / M D / Promoter
S Sambhuprasad
Non-Exec & Non-Independent Dir
Ramaa Prabhakar Arikirevula
Non-Exec & Non-Independent Dir
G Raghavan
Independent Non Exe. Director
V Raja
Independent Non Exe. Director
Muralidharan Swayambunathan
Independent Non Exe. Director
Meena Lochani Raghunathan
Independent Non Exe. Director
V Nagaraj
CS / Compliance Officer / General Manager - Legal
GAGAN PREET SINGH
New 103 Old 42-45 LuzChurch Rd,
Mylapore,
Tamil Nadu - 600004
Tel: 91-44-24994164/24994465/24994366
Website: http://www.amrutanjan.com
Email: investors@amrutanjan.com; customercare@amrutanjan.
Subramanian Building,
1ST Floor No 1, Club House Road,
Chennai - 600002
Tel: 91-44-28462700
Website: www.cameoindia.com
Email: investor@cameoindia.com
Summary
Amrutanjan Health Care Limited (AHCL) was incorporated on September 9, 1936 in Chennai, Tamil Nadu. The Chennai-based Amrutanjan manufactures bulk drugs and drug intermediates like theophylline, based...
Read More
Reports by Amrutanjan Health Care Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.